Optional: Sermorelin Thyroid Panel (Quest)

$127.00

A focused lab panel designed to monitor thyroid function in individuals using sermorelin therapy. Recommended every 6-12 months to support safe, effective, and personalized treatment over time or sooner if clinical indicated.

Prescription treatments include a short medical intake at checkout. A licensed clinician reviews every order before anything is prescribed or shipped — if it is not approved, you are fully refunded.

Product details

What this panel includes

  • TSH: Assesses thyroid signaling and feedback regulation

  • Free T4: Evaluates thyroid hormone production

  • Free T3: Reflects active thyroid hormone availability at the tissue level

Biomarkers tested

T3, FreeTSHT4 Free (FT4)

Why patients choose this

  • A targeted check of key thyroid markers to help maintain hormonal balance during sermorelin therapy.
  • Offers insight into how the thyroid is responding while on ongoing growth hormone support.
  • Recommended at six-month intervals for those actively using sermorelin or on longer-term growth hormone support protocols.
  • Schedule your lab test seamlessly and complete it at a lab near you.

Before your test

It is recommended to fast for at least 8 hours before.

Important information

Why it matters: sermorelin stimulates the body's natural growth hormone signaling, which can influence downstream hormonal systems over time, including thyroid function, so regular monitoring helps identify early changes, optimize dosing, and support long-term treatment safety.

Who it's for: recommended, not required, at six-month intervals for individuals actively using sermorelin or undergoing longer-term growth hormone support protocols.

It is recommended to fast for at least 8 hours before your draw.

Licensed pharmacies

Medications sourced from 503A and 503B U.S.-licensed pharmacies.

Certified labs

Lab testing conducted through CLIA-certified laboratories.

Expert clinicians

Care delivered by board-certified clinicians.

Nationwide care

Available in all 50 states and Washington, D.C.